<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0033">
 <label>33.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Loi</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Sirtaine</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Piette</surname>
   <given-names>F</given-names>
  </string-name>, et al. 
  <article-title>Prognostic and predictive value of tumor-infiltrating lymphocytes in a Phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98</article-title>. 
  <source>
   <italic toggle="yes">J Clin Oncol</italic>
  </source>. 
  <year>2013</year>;
  <volume>31</volume>(
  <issue>7</issue>):
  <fpage>860</fpage>â€“
  <lpage>867</lpage>. doi:
  <pub-id pub-id-type="doi">10.1200/JCO.2011.41.0902</pub-id>
  <pub-id pub-id-type="pmid">23341518</pub-id>
 </mixed-citation>
</ref>
